Nixon Peabody Trust’s Clorox CLX Stock Holding History

Nixon Peabody Trust’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,329	Closed	-$203K	–	130
2024 Q1	$203K	Buy	+1,329	New	+$198K	0.02%	123

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Nixon Peabody Trust's CLX Position: Q2 2024 in Review

Nixon Peabody Trust sold out of Clorox (CLX) in Q2 2024, closing a stake of 1,329 shares — an estimated $203K sold.

Nixon Peabody Trust first reported a position in CLX in Q1 2024 and held it in 1 quarter. The position peaked at $203K in Q1 2024. 1,091 funds tracked by Wall St. Rank hold CLX as of Q2 2024.

Nixon Peabody Trust reported no remaining Clorox position as of Q2 2024 after selling out during the quarter.
Nixon Peabody Trust sold 1,329 Clorox shares in Q2 2024, an estimated $203K.
Nixon Peabody Trust first reported a position in Clorox in Q1 2024 and held it in 1 quarter.
Nixon Peabody Trust's Clorox position peaked at $203K in Q1 2024.
1,091 funds tracked by Wall St. Rank held Clorox as of Q2 2024.

Based on Nixon Peabody Trust's 13F filing for Q2 2024, filed 26 Jul 2024.